| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
Mus musculus
|
SRA Run Selector
|
Chuan Li
|
||||||
| GSM4377039 |
Ambra1_KPTC
|
SRA |
|
1 |
|
Chuan Li | Feb 04, 2021 | ||
| GSM4377037 |
Ambra1_KT
|
SRA |
|
1 |
|
Chuan Li | Feb 04, 2021 | ||
| GSM4377038 |
Ambra1_KTC
|
SRA |
|
1 |
|
Chuan Li | Feb 04, 2021 | ||
| GSM4376999 |
KTC_sg-102-Pool_15Wks
|
SRA |
|
1 |
|
Chuan Li | Feb 04, 2021 | ||
| GSM4377001 |
KTC_sg-85-Pool_15Wks
|
SRA |
|
1 |
|
Chuan Li | Feb 04, 2021 | ||
| GSM4377003 |
KTC_sg-85-Pool_26Wks
|
SRA |
|
1 |
|
Chuan Li | Feb 04, 2021 | ||
| GSM4376998 |
KT_sg-102-Pool_15Wks
|
SRA |
|
1 |
|
Chuan Li | Feb 04, 2021 | ||
| GSM4377000 |
KT_sg-85-Pool_Ctrl for 15Wks
|
SRA |
|
1 |
|
Chuan Li | Feb 04, 2021 | ||
| GSM4377002 |
KT_sg-85-Pool_Ctrl for 26Wks
|
SRA |
|
1 |
|
Chuan Li | Feb 04, 2021 | ||
| GSM4386018 |
Pharma_KT_Paclitaxel+Trametinib+Carbo_Tumors
|
SRA |
|
1 |
|
Chuan Li | Mar 05, 2021 | ||
| GSM4386017 |
Pharma_KT_Untreated_Tumors
|
SRA |
|
1 |
|
Chuan Li | Mar 05, 2021 | ||
| GSM4386010 |
Pharma_Mapping_Everolimus_Tumors
|
SRA |
|
1 |
|
Chuan Li | Mar 05, 2021 | ||
| GSM4386015 |
Pharma_Mapping_Paclitaxel+Carbo_Tumors
|
SRA |
|
1 |
|
Chuan Li | Mar 05, 2021 | ||
| GSM4386016 |
Pharma_Mapping_Paclitaxel+Trametinib+Carbo_Tumors
|
SRA |
|
1 |
|
Chuan Li | Mar 05, 2021 | ||
| GSM4386014 |
Pharma_Mapping_Paclitaxel+Trametinib_Tumors
|
SRA |
|
1 |
|
Chuan Li | Mar 05, 2021 | ||
| GSM4386012 |
Pharma_Mapping_Paclitaxel_Tumors
|
SRA |
|
1 |
|
Chuan Li | Mar 05, 2021 | ||
| GSM4386009 |
Pharma_Mapping_Palbociclib_Tumors
|
SRA |
|
1 |
|
Chuan Li | Mar 05, 2021 | ||
| GSM4386011 |
Pharma_Mapping_Phenformin_Tumors
|
SRA |
|
1 |
|
Chuan Li | Mar 05, 2021 | ||
| GSM4386013 |
Pharma_Mapping_Trametinib_Tumors
|
SRA |
|
1 |
|
Chuan Li | Mar 05, 2021 | ||
| GSM4386008 |
Pharma_Mapping_Untreated_Tumors
|
SRA |
|
1 |
|
Chuan Li | Mar 05, 2021 |
